Patents by Inventor Philip R. Greipp

Philip R. Greipp has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Cytogenetically determined prognosis of myeloma
    Patent number: 7662579
    Abstract: The invention provides methods and materials for determining a prognosis for myeloma and myeloma-disposed patients. The methods include the use of FISH techniques. The identification of the chromosomal abnormalities t(4;14)(p16;q32), t(14;16)(q32;q23), or 17p13 deletion (p53) in plasma cells from a patient indicates a poor prognosis.
    Type: Grant
    Filed: November 10, 2003
    Date of Patent: February 16, 2010
    Assignee: Mayo Foundation for Medical Education and Research
    Inventors: Rafael Fonseca, Philip R. Greipp
  • Cytogenetically determined prognosis of myeloma
    Publication number: 20040101898
    Abstract: The invention provides methods and materials for determining a prognosis for myeloma and myeloma-disposed patients. The methods include the use of FISH techniques. The identification of the chromosomal abnormalities t(4;14)(p16;q32), t(14;16)(q32;q23), or 17p13 deletion (p53) in plasma cells from a patient indicates a poor prognosis.
    Type: Application
    Filed: November 10, 2003
    Publication date: May 27, 2004
    Inventors: Rafael Fonseca, Philip R. Greipp
  • Detection of cellular DNA
    Patent number: 4885237
    Abstract: A method is described for the detection of halodeoxyuridines taken up by cells during DNA synthesis by the use of monoclonal antibodies. The described method also allows the simultaneous detection of cell surface receptors.
    Type: Grant
    Filed: June 6, 1988
    Date of Patent: December 5, 1989
    Assignee: Becton, Dickinson and Company
    Inventors: Elizabeth L. Evans, Nick J. Gonchoroff, Philip R. Greipp, David W. Houck, Jerry A. Katzmann, Robert A. Kyle, Michael R. Loken